Pulmonology

The supplemental approval for Tyvaso comes on the basis of clinical evidence showing benefit for pulmonary and cardiovascular outcomes in adult patients.

The Harmony Transcatheter Pulmonary Valve System is designed to treat adult and pediatric patients with pulmonary valve regurgitation.

On World TB Day, experts from the ALA and CDC reflect on the recent issues of tuberculosis.

In commemoration of World TB Day, a CDC and ALA expert discuss how TB still exists in the country.

CDC tuberculosis lead Dr. Phillip LoBue joins to discuss the past and present issues of the disease, in time for TB Awareness Day on March 24.

Nearly 60% of children with MIS-C are admitted to the hospital for intensive care.

A pooled analysis of sleep disturbance-related outcomes showed the IgE inhibitor significantly benefits a burdensome symptom of CRSwNP.

From interpreting currently-understood risks to managing isolation-induced indoor allergen exposure, asthmatics may have concerns they address with clinicians.

A review of 3 new studies, which indicate the association between severe COVID-19 and the chronic disease is more intricate than previously thought.

The application, submitted by Merck, is based on data from 2 clinical trials evaluating patients with refractory or unexplained chronic cough.

From better education, to remote monitoring and consistent check-ins, clinicians may need to initiate better adherence in their younger, severely ill patients.

An interview on the TSLP inhibitor's effect on exacerbations, hospitalizations, and disease progress over 52-week findings.

Oxygen saturation levels similar for both asthma patients and non-asthma patients following mask use.

MYMD-1 targets the root cause of inflammation for patients with IPF.

New survey results depict unexpected burdens in long-haul patients, as well as continued issues following rehabilitation.

Common positive effects includes help with sleep, less pain, and calming influence.

An interview with a study author on new interpretations of biologic asthma benefit.

Treatment showed a similar effect on patients with and without baseline asthma.

Researchers explore further endpoints from the SINUS-24 and SINUS-52 trials.

In data presented at AAAAI 2021, researchers present new data from the LIBERTY ASTHMA QUEST trial.

New research show the novel DNRI benefits patients both adherent and not to their OSA primary therapy.

Partnerships between primary care physicians and pulmonologists may improve vaccination rates for patients with COPD.

The monoclonal antibody may provide a novel treatment pathway for the chronic, often deadly pulmonary disease.

The co-lead investigators discuss the upcoming first study to assess long-term outcomes on MIS-C patients.

A cohort assessment shows a 57% increased risk of pediatric asthma development among children given PPIs to treat gastrointestinal tract disorders.